Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications: below specification
Products
  • Ranolazine Extended-Release Tablets
Where it was sold

Nationwide in the US.

Nationwide

About this recall
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02